These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2940340)

  • 1. Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia.
    Duijndam-van den Berge M; Goekoop JG
    J Neurol Neurosurg Psychiatry; 1986 May; 49(5):595-8. PubMed ID: 2940340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies of Down's syndrome and Alzheimer's disease.
    Walford RL
    Ann N Y Acad Sci; 1982; 396():95-106. PubMed ID: 6295240
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte capping in Down's syndrome and Alzheimer's disease.
    Brohée D
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):370. PubMed ID: 2951500
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in concanavalin A capping of human lymphocytes with age.
    Noronha AB; Antel JP; Roos RP; Arnason BG
    Mech Ageing Dev; 1980 Apr; 12(4):331-7. PubMed ID: 7392675
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal serum IgG subclass pattern in children with Down's syndrome.
    Annerén G; Magnusson CG; Lilja G; Nordvall SL
    Arch Dis Child; 1992 May; 67(5):628-31. PubMed ID: 1534650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
    Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
    Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals.
    Naeim F; Walford RL
    J Gerontol; 1980 Sep; 35(5):650-5. PubMed ID: 6448891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive executive function in Down's syndrome.
    Rowe J; Lavender A; Turk V
    Br J Clin Psychol; 2006 Mar; 45(Pt 1):5-17. PubMed ID: 16480563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy, dementia and adaptive behaviour in Down's syndrome.
    Collacott RA
    J Intellect Disabil Res; 1993 Apr; 37 ( Pt 2)():153-60. PubMed ID: 8481613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte subpopulations in Down's syndrome].
    Mori M; Zaike Y; Takeda T
    Rinsho Ketsueki; 1986 Oct; 27(10):1829-33. PubMed ID: 2950258
    [No Abstract]   [Full Text] [Related]  

  • 18. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte surface phenotypes in Down's syndrome.
    Bertotto A; Lungarotti MS; Gentili F; Vaccaro R
    Int J Tissue React; 1984; 6(3):219-21. PubMed ID: 6237071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte concanavalin A capping in hereditary cerebral haemorrhage with amyloidosis--Dutch type.
    Haan J; Demmers RT; Buruma OJ; Roos RA
    J Neurol; 1990 Apr; 237(2):117-9. PubMed ID: 2355236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.